Reduction of PaCO2 by high-flow nasal cannula in acute hypercapnic respiratory failure patients receiving conventional oxygen therapy
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background: It has been suggested that a high-flow nasal cannula (HFNC) could help to remove carbon dioxide (CO2) from anatomical dead spaces, but evidence to support that is lacking. The objective of this study was to elucidate whether use of an HFNC could reduce the arterial partial pressure of CO2 (PaCO2) in patients with acute hypercapnic respiratory failure who are receiving conventional oxygen (O2) therapy. Methods: A propensity score-matched observational study was conducted to evaluate patients treated with an HFNC for acute hypercapnic respiratory failure from 2015 to 2016. The hypercapnia group was defined as patients with a PaCO2 >50 mm Hg and arterial pH <7.35. Results: Eighteen patients in the hypercapnia group and 177 patients in the nonhypercapnia group were eligible for the present study. Eighteen patients in each group were matched by propensity score. Decreased PaCO2 and consequent pH normalization over time occurred in the hypercapnia group (P=0.002 and P=0.005, respectively). The initial PaCO2 level correlated linearly with PaCO2 removal after the use of an HFNC (R2=0.378, P=0.010). The fraction of inspired O2 used in the intensive care unit was consistently higher for 48 hours in the non-hypercapnia group. Physiological parameters such as respiratory rate and arterial partial pressure of O2 improved over time in both groups. Conclusions: Physiological parameters can improve after the use of an HFNC in patients with acute hypercapnic respiratory failure given low-flow O2 therapy via a facial mask. Further studies are needed to identify which hypercapnic patients might benefit from an HFNC.
Abstract
Background: It has been suggested that a high-flow nasal cannula (HFNC) could help to remove carbon dioxide (CO2) from anatomical dead spaces, but evidence to support that is lacking. The objective of this study was to elucidate whether use of an HFNC could reduce the arterial partial pressure of CO2 (PaCO2) in patients with acute hypercapnic respiratory failure who are receiving conventional oxygen (O2) therapy. Methods: A propensity score-matched observational study was conducted to evaluate patients treated with an HFNC for acute hypercapnic respiratory failure from 2015 to 2016. The hypercapnia group was defined as patients with a PaCO2 >50 mm Hg and arterial pH <7.35. Results: Eighteen patients in the hypercapnia group and 177 patients in the nonhypercapnia group were eligible for the present study. Eighteen patients in each group were matched by propensity score. Decreased PaCO2 and consequent pH normalization over time occurred in the hypercapnia group (P=0.002 and P=0.005, respectively). The initial PaCO2 level correlated linearly with PaCO2 removal after the use of an HFNC (R2=0.378, P=0.010). The fraction of inspired O2 used in the intensive care unit was consistently higher for 48 hours in the non-hypercapnia group. Physiological parameters such as respiratory rate and arterial partial pressure of O2 improved over time in both groups. Conclusions: Physiological parameters can improve after the use of an HFNC in patients with acute hypercapnic respiratory failure given low-flow O2 therapy via a facial mask. Further studies are needed to identify which hypercapnic patients might benefit from an HFNC.
참고문헌 (29)
- Hernández G, "High-flow nasal cannula support therapy : new insights and improving performance", Crit Care, 21, pp.62~ (2017)
- Curley GF, "Noninvasive respiratory support for acute respiratory failure-high flow nasal cannula oxygen or non-invasive ventilation?", J Thorac Dis, 7, pp.1092~1097 (2015)
- Nishimura M, "High-flow nasal cannula oxygen therapy in adults", J Intensive Care, 3, pp.15~ (2015)
- Dysart K, "Research in high flow therapy : mechanisms of action", Respir Med, 103, pp.1400~1405 (2009)
- Sztrymf B, "Impact of high-flow nasal cannula oxygen therapy on intensive care unit patients with acute respiratory failure : a prospective observational study", J Crit Care, 27, pp.324~ (2012)
- Itagaki T, "Effect of high-flow nasal cannula on thoraco-abdominal synchrony in adult critically ill patients", Respir Care, 59, pp.70~74 (2014)
- Möller W, "Nasal high flow clears anatomical dead space in upper airway models", J Appl Physiol(1985), 118, pp.1525~1532 (2015)
- Mündel T, "Mechanisms of nasal high flow on ventilation during wakefulness and sleep", J Appl Physiol(1985), 114, pp.1058~1065 (2013)
- Corley A, "Oxygen delivery through high-flow nasal cannulae increase endexpiratory lung volume and reduce respiratory rate in postcardiac surgical patients", Br J Anaesth, 107, pp.998~1004 (2011)
- Riera J, "Effect of high-flow nasal cannula and body position on end-expiratory lung volume : a cohort study using electrical impedance tomography", Respir Care, 58, pp.589~596 (2013)
- Davidson AC, "BTS", ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults, 2016, pp.71(Suppl 2), ii1~ii35
- Diaz O, "Effects of noninvasive ventilation on pulmonary gas exchange and hemodynamics during acute hypercapnic exacerbations of chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 156, pp.1840~1845 (1997)
- Schönhofer B, "Equipment needs for noninvasive mechanical ventilation", Eur Respir J, 20, pp.1029~1036 (2002)
- Mehta S, "Noninvasive ventilation", Am J Respir Crit Care Med, 163, pp.540~577 (2001)
- Fraser JF, "Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes : a randomized crossover trial", Thorax, 71, pp.759~761 (2016)
- Bräunlich J, "Nasal highflow improves ventilation in patients with COPD", Int J Chron Obstruct Pulmon Dis, 11, pp.1077~1085 (2016)
- Chatila W, "The effects of high-flow vs low-flow oxygen on exercise in advanced obstructive airways disease", Chest, 126, pp.1108~1115 (2004)
- Pilcher J, "Physiological effects of titrated oxygen via nasal highflow cannulae in COPD exacerbations : a randomized controlled cross-over trial", Respirology, 22, pp.1149~1155 (2017)
- British Thoracic Society Standards of Care Committee, "Noninvasive ventilation in acute respiratory failure", Thorax, 57, pp.192~211 (2002)
- Rawat D, "Hypercapnea" (2019), StatPearls Publishing
- Jubran A, "Mechanical ventilation and weaning", pp.161~168 (2002), Springer Berlin-Heidelberg
- Miro AM, "Continuous positive airway pressure in COPD patients in acute hypercapnic respiratory failure", Chest, 103, pp.266~268 (1993)
- Jaoude P, "Survival benefit of CPAP favors hypercapnic patients with the overlap syndrome", Lung, 192, pp.251~258 (2014)
- Mauri T, "High flow nasal cannula improves lung aeration and enhances CO2 removal in hypoxemic critically ill patients", Intensive Care Med Exp, 3, pp.A176~ (2015)
- Austin MA, "Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial", BMJ, 341, pp.c5462~ (2010)
- Chang GY, "Nasal cannula, CPAP, and highflow nasal cannula : effect of flow on temperature, humidity, pressure, and resistance", Biomed Instrum Technol, 45, pp.69~74 (2011)
- Jeffrey AA, "Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease : risk factors and use of guidelines for management", Thorax, 47, pp.34~40 (1992)
- Lee CC, "High flow nasal cannula versus conventional oxygen therapy and non-invasive ventilation in adults with acute hypoxemic respiratory failure: a systematic review", Respir Med, 121, pp.100~108 (2016)
- Coudroy R, "Highflow nasal cannula oxygen therapy versus noninvasive ventilation in immunocompromised patients with acute respiratory failure : an observational cohort study", Ann Intensive Care, 6, pp.45~ (2016)